Ischemia/reperfusion Activates Myocardial Innate Immune Response: the Key Role of the Toll-like Receptor

Overview

Journal Front Physiol

Date 2015 Jan 8

PMID 25566092

Citations 67

Authors

Gemma Vilahur

Lina Badimon

Affiliations

Soon will be listed here.

Abstract

Recent data have indicated that the myocardium may act as an immune organ initiating cardiac innate immune response and inflammation. It has been suggested that activation of the immune system occurs upon the interaction of damage-associated molecular patterns (DAMPs) generated and released during ischemic damage with pattern recognition receptors (Toll like receptors; TLR) present in cardiac cells. Among TLRs, TLR4, and TLR2 are the ones mostly expressed in cardiac tissue. Whereas TLR4 has shown to play a detrimental role in myocardial ischemia/reperfusion (I/R) injury, the effect elicited by TLR2 activation remains controversial. Once activated, TLR signaling may occur via the Myd88- and Trif- dependent pathways leading to NFκB and IFN-3 activation, respectively, and subsequent stimulation of pro-inflammatory and immunomodulatory cytokine gene expression. Cytokine release contributes to neutrophils activation, recruitment, adhesion and infiltration to the site of cardiac injury further perpetuating the inflammatory process. This mini-review will focus on the current knowledge regarding the role of the heart in inducing and coordinating the innate inflammatory response via the TLR signaling pathway in myocardial I/R injury.

Citing Articles

Vagal nerve stimulation in myocardial ischemia/reperfusion injury: from bench to bedside.

Giannino G, Nocera L, Andolfatto M, Braia V, Giacobbe F, Bruno F Bioelectron Med. 2024; 10(1):22.

PMID: 39267134 PMC: 11395864. DOI: 10.1186/s42234-024-00153-6.

The Influence of Metabolic Risk Factors on the Inflammatory Response Triggered by Myocardial Infarction: Bridging Pathophysiology to Treatment.

Ramos-Regalado L, Alcover S, Badimon L, Vilahur G Cells. 2024; 13(13.

PMID: 38994977 PMC: 11240659. DOI: 10.3390/cells13131125.

Immunometabolism at the Heart of Cardiovascular Disease.

DeBerge M, Chaudhary R, Schroth S, Thorp E JACC Basic Transl Sci. 2023; 8(7):884-904.

PMID: 37547069 PMC: 10401297. DOI: 10.1016/j.jacbts.2022.12.010.

Short-term toll-like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarction.

Lenz M, Kiss A, Haider P, Salzmann M, Brekalo M, Krychtiuk K ESC Heart Fail. 2023; 10(4):2375-2385.

PMID: 37190856 PMC: 10375131. DOI: 10.1002/ehf2.14403.

CREB1 and PPAR-α/γ Pathways in Hepatic Ischemia/Reperfusion: Route for Curcumin to Hepatoprotection.

Demir E, Tutuk O, Dogan-Gocmen H, Ozyilmaz D, Karagul M, Kara M Iran J Pharm Res. 2023; 21(1):e133779.

PMID: 36942070 PMC: 10024335. DOI: 10.5812/ijpr-133779.

References

Ha T, Liu L, Kelley J, Kao R, Williams D, Li C . Toll-like receptors: new players in myocardial ischemia/reperfusion injury. Antioxid Redox Signal. 2010; 15(7):1875-93. PMC: 3159106. DOI: 10.1089/ars.2010.3723. View

Anderson K, Bokla L, Nusslein-Volhard C . Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell. 1985; 42(3):791-8. DOI: 10.1016/0092-8674(85)90275-2. View

Ao L, Zou N, Cleveland Jr J, Fullerton D, Meng X . Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70. Am J Physiol Heart Circ Physiol. 2009; 297(1):H21-8. PMC: 2711729. DOI: 10.1152/ajpheart.00292.2009. View

Kiechl S, Lorenz E, Reindl M, Wiedermann C, Oberhollenzer F, Bonora E . Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 2002; 347(3):185-92. DOI: 10.1056/NEJMoa012673. View

Scheibner K, Lutz M, Boodoo S, Fenton M, Powell J, Horton M . Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol. 2006; 177(2):1272-81. DOI: 10.4049/jimmunol.177.2.1272. View

Frantz S, Kobzik L, Kim Y, Fukazawa R, Medzhitov R, Lee R . Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest. 1999; 104(3):271-80. PMC: 408420. DOI: 10.1172/JCI6709. View

Chao W . Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol. 2008; 296(1):H1-12. PMC: 2637783. DOI: 10.1152/ajpheart.00995.2008. View

Flohe L, Brigelius-Flohe R, Saliou C, Traber M, Packer L . Redox regulation of NF-kappa B activation. Free Radic Biol Med. 1997; 22(6):1115-26. DOI: 10.1016/s0891-5849(96)00501-1. View

Wang Y, Abarbanell A, Herrmann J, Weil B, Poynter J, Manukyan M . Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury. Shock. 2010; 34(6):548-57. DOI: 10.1097/SHK.0b013e3181e686f5. View

10.

Lin E, Freedman J, Beaulieu L . Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases. Cardiovasc Ther. 2009; 27(2):117-23. PMC: 2832843. DOI: 10.1111/j.1755-5922.2009.00077.x. View

11.

Kim S, Ghanem A, Stapel H, Tiemann K, Knuefermann P, Hoeft A . Toll-like receptor 4 deficiency: smaller infarcts, but no gain in function. BMC Physiol. 2007; 7:5. PMC: 1933437. DOI: 10.1186/1472-6793-7-5. View

12.

Vilahur G, Juan-Babot O, Pena E, Onate B, Casani L, Badimon L . Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. J Mol Cell Cardiol. 2011; 50(3):522-33. DOI: 10.1016/j.yjmcc.2010.12.021. View

13.

Scaffidi P, Misteli T, Bianchi M . Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002; 418(6894):191-5. DOI: 10.1038/nature00858. View

14.

Vilahur G, Hernandez-Vera R, Molins B, Casani L, Duran X, Padro T . Short-term myocardial ischemia induces cardiac modified C-reactive protein expression and proinflammatory gene (cyclo-oxygenase-2, monocyte chemoattractant protein-1, and tissue factor) upregulation in peripheral blood mononuclear cells. J Thromb Haemost. 2008; 7(3):485-93. DOI: 10.1111/j.1538-7836.2008.03244.x. View

15.

Aikawa R, Nagai T, Tanaka M, Zou Y, Ishihara T, Takano H . Reactive oxygen species in mechanical stress-induced cardiac hypertrophy. Biochem Biophys Res Commun. 2001; 289(4):901-7. DOI: 10.1006/bbrc.2001.6068. View

16.

Chong A, Shimamoto A, Hampton C, Takayama H, Spring D, Rothnie C . Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg. 2004; 128(2):170-9. DOI: 10.1016/j.jtcvs.2003.11.036. View

17.

Lemaitre B, Nicolas E, Michaut L, Reichhart J, Hoffmann J . The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 1996; 86(6):973-83. DOI: 10.1016/s0092-8674(00)80172-5. View

18.

Oyama J, Blais Jr C, Liu X, Pu M, Kobzik L, Kelly R . Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation. 2004; 109(6):784-9. DOI: 10.1161/01.CIR.0000112575.66565.84. View

19.

Bolli R, Marban E . Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 1999; 79(2):609-34. DOI: 10.1152/physrev.1999.79.2.609. View

20.

Dong J, Vallejo J, Tzeng H, Thomas J, Mann D . Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways. Am J Physiol Heart Circ Physiol. 2010; 298(3):H1079-87. PMC: 2838552. DOI: 10.1152/ajpheart.00306.2009. View